Ms. Jackson is an accomplished executive sales leader with a documented 20 year history of success within the commercial and government healthcare sectors. She demonstrates excellence in REMS-governed products and ultra-rare disease therapeutics.  She acts as a trusted resource amongst her colleagues, with a prowess most notable in patient access, provider reimbursement and formulary successes spanning over a decade. Prior to joining Maclean, she played key sales leadership roles in several product launches in the biotechnology startup space. Most recently Ms. Jackson is credited with her administrative and commercial operations strength, providing crucial direction to her family’s internal medicine practice, through the challenges and changes born of the COVID-19 pandemic.